(801) 545-4000
Direct Lender
Broker Success
$250K to $300M Per Project
Bank Project Financing
CFPs Banker Promise
Non-admitted asset financing lets an insurance company sell assets that don't count toward statutory surplus — data systems, software, furniture, equipment — and lease them back, converting their value into admitted cash. Commercial Funding Partners structures these transactions under statutory accounting principles (SAP) and NAIC guidelines, so the surplus relief holds up in your filings. If inflation-driven claims costs, a risk-based capital ratio under pressure, or a rating agency review have you looking for surplus, the assets already on your books may be the fastest answer.
Request a Quote
Under SAP, certain assets are excluded from statutory surplus no matter what they're worth — furniture and fixtures, EDP equipment beyond the admitted cap, software, leasehold improvements. They have real value; the accounting just can't see it. Our program uses an equipment sale-leaseback structure adapted for insurers: CFP purchases the non-admitted assets at fair market value, you lease them back and keep using them without interruption, and the sale proceeds arrive as cash — an admitted asset that strengthens surplus immediately.
Because insurance transactions get scrutiny that ordinary equipment deals don't, our institutional equipment funding desk handles the structuring, working alongside your CFO, auditors, and, where appropriate, your domiciliary regulator. Our team has structured transactions for rated carriers where documentation standards and closing timing both mattered.
Turn assets the statutory balance sheet ignores into cash it recognizes.
Strengthen surplus and risk-based capital ratios without raising capital or ceding more business
Build a cash buffer ahead of cat season, rate reviews, or regulatory exams.
Lease terms built around your filing calendar and cash-flow profile, not a template.
This program is suited for:
P&C carriers absorbing outsized claims after natural disasters or in high-risk regions can rebuild surplus without waiting on rate increases.
Health insurers facing sudden claims spikes or coverage-regulation changes can monetize non-admitted assets to steady the balance sheet.
Life companies managing long-term policyholder obligations can free up surplus while keeping every system and asset in service.
Reinsurers holding capital against diversified risk can add an admitted-cash layer without touching their investment portfolio.
Surety writers with concentrated contractor risk can strengthen the capital position that backs their bonds.
Cat-focused carriers can build the liquid reserves that hurricane, earthquake, and flood claims demand — before the season, not after.
A non-admitted asset is one that statutory accounting principles exclude from an insurer's surplus calculation — commonly furniture and fixtures, software, EDP equipment above the admitted threshold, leasehold improvements, and certain receivables. The asset has real economic value, but it doesn't count toward the surplus regulators and rating agencies measure.
Through a sale-leaseback: the insurer sells non-admitted assets to CFP at fair market value and leases them back. The assets stay in use, but the sale proceeds arrive as cash — an admitted asset — so statutory surplus increases by the transaction amount, subject to the insurer's accounting treatment.
CFP structures each transaction with statutory accounting principles and NAIC guidance in view, and works alongside the insurer's auditors during documentation. Every carrier's situation differs, so your accounting team and, where relevant, your domiciliary regulator make the final determination on treatment.
Property and casualty carriers, health and life insurers, reinsurers, surety writers, and catastrophe-focused companies — typically when claims pressure, RBC ratios, or a pending rating review make near-term surplus relief valuable.nciples and NAIC guidance in view, and works alongside the insurer's auditors during documentation. Every carrier's situation differs, so your accounting team and, where relevant, your domiciliary regulator make the final determination on treatment.
